Jubilant Ingrevia has raised Rs 100 crore through Commercial Papers (CPs). The maturity of the said Commercial Papers will be on February 24, 2025. Tenure of the instrument is 75 days. The Finance Committee, at its meeting held on October 23, 2024 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches.
The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 200 crore.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
